Recombinant MYL3/CMLC1 antibody

Catalog No. ABIN7828414

This Rabbit Monoclonal antibody specifically detects MYL3/CMLC1 in WB, IHC and FACS. It exhibits reactivity toward Human, Mouse and Rat.

Quick Overview for Recombinant MYL3/CMLC1 antibody (ABIN7828414)

Target: MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))

Antibody Type: Recombinant Antibody

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Monoclonal

Conjugate: This MYL3/CMLC1 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Clone: A310

Product Details anti-MYL3/CMLC1 Antibody

Purpose: Recombinant Myosin Light Chain 3 Monoclonal Antibody

Purification: Protein A purified

Immunogen: Recombinant human Myosin Light Chain 3 fragment

Isotype: IgG, kappa

Application Details

Application Notes: WB 1:500-1:2000,IHC 1:200-1:1000,FCM 1:50-1:100

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Expiry Date: 12 months

Target Details for MYL3/CMLC1

Target: MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))

Alternative Name: Myosin Light Chain 3

Background: Myl,MYL3,alkali,Cardiac myosin light chain 1,CMH8,CMLC1,ELC of myosin,Essential light chain of myosin,light chain 1,light chain 3,light polypeptide 3,MLC1SB,MLC1V,Myosin,Myosin light chain 1,Myosin light chain 1 slow,Myosin light chain 1 slow twitch muscle B/ventricular isoform,Myosin light chain 3,OTTHUMP00000165922,skeletal,slow,Slow skeletal ventricular myosin alkali light chain 3,slow-twitch muscle B/ventricular isoform,ventricular,Ventricular/slow twitch myosin alkali light chain,VLC1,MYL3, also named as MLC1v, is an essential light chain of myosin that is associated with muscle contraction. It is expressed in ventricular and slow skeletal muscle. MYL3 may serve as a target for caspase-3 in dying cardiomyocytes. Mutations of MYL3 gene cause hypertrophic cardiomyopathy. MYL3 has been identified as potential serum biomarker for drug induced myotoxicity. Great increase in MYL3 serum concentration has been observed in rats with cardiac and skeletal muscle injury. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

Molecular Weight:

Calculated MW: 22 kDa

Observed MW: 22 kDa

UniProt: P08590